Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
raleigh-durham blog main
san francisco blog main
san francisco top stories
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
celgene
deals
fda
intercept pharmaceuticals
medical device
startups
2019
4d molecular therapeutics
abbvie
acne
activism
acute hepatic porphyria
What
disease
4
×
drug
4
×
bio
liver
race
roundup
therapy
advanced
alnylam’s
alzheimer's
approval
approved
bad
bff
brain
building
cancer
case
companies
conference
deal
deals
developer
devoted
digital
doses
easl
epidemic
established
failed
fatty
fda
fight
firm
form
fortune
frenzied
gene
goes
growing
Language
Current search:
biotech
×
disease
×
" san francisco top stories "
×
drug
×
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed